13F Pro

SEC Form 4 reporting owner

Lin Xichen

Lin Xichen has filed 23 Form 4 transactions reported between March 3, 2026 and September 1, 2026, as CHIEF SCIENTIFIC OFFICER of Structure Therapeutics Inc..

Name as filed: Lin Xichen

Open-market buys, 24 mo
None
reported
Open-market sales, 24 mo
$1.1M
10 lines
Companies
1
with Form 4 filings
Latest transaction
Sep 1, 2026
transaction date

Roles and reported holdings

  • GPCRStructure Therapeutics Inc.
    Mar 3, 2026 – Sep 1, 2026

    CHIEF SCIENTIFIC OFFICER

    Held directly0 sh as of Sep 1, 2026 · Form 4

    24 months: $1.1M sold

Transaction history

All 23 reported transactions, newest first. Every row links to the Form 4 on SEC EDGAR.

DateCompanyTypeSharesValueFiling
Sep 1, 2026GPCRCHIEF SCIENTIFIC OFFICEROpen-market saleCode S · direct100$5K@ $47.83Form 4
Sep 1, 2026GPCRCHIEF SCIENTIFIC OFFICEROpen-market saleCode S · direct4,539$214K@ $47.20Form 4
Sep 1, 2026GPCRCHIEF SCIENTIFIC OFFICEROpen-market saleCode S · direct1,300$60K@ $45.86Form 4
Sep 1, 2026GPCRCHIEF SCIENTIFIC OFFICERConversion of derivativeCode C · direct5,939—Form 4
Sep 1, 2026GPCRCHIEF SCIENTIFIC OFFICEROption exerciseCode M · direct17,817$6K@ $0.3400Form 4
Aug 18, 2026GPCRCHIEF SCIENTIFIC OFFICEROpen-market saleCode S · direct400$22K@ $55.05Form 4
Aug 18, 2026GPCRCHIEF SCIENTIFIC OFFICEROpen-market saleCode S · direct519$28K@ $54.20Form 4
Aug 18, 2026GPCRCHIEF SCIENTIFIC OFFICEROpen-market saleCode S · direct3,020$160K@ $53.13Form 4
Aug 18, 2026GPCRCHIEF SCIENTIFIC OFFICERConversion of derivativeCode C · direct3,939—Form 4
Aug 18, 2026GPCRCHIEF SCIENTIFIC OFFICEROption exerciseCode M · direct11,817$4K@ $0.3400Form 4
Aug 4, 2026GPCRCHIEF SCIENTIFIC OFFICEROpen-market saleCode S · direct839$42K@ $50.03Form 4
Aug 4, 2026GPCRCHIEF SCIENTIFIC OFFICEROpen-market saleCode S · direct3,100$153K@ $49.29Form 4
Aug 4, 2026GPCRCHIEF SCIENTIFIC OFFICERConversion of derivativeCode C · direct3,939—Form 4
Aug 4, 2026GPCRCHIEF SCIENTIFIC OFFICEROption exerciseCode M · direct11,817$4K@ $0.3400Form 4
Jul 14, 2026GPCRCHIEF SCIENTIFIC OFFICEROpen-market saleCode S · direct1,600$83K@ $51.71Form 4
Jul 14, 2026GPCRCHIEF SCIENTIFIC OFFICEROpen-market saleCode S · direct6,278$319K@ $50.80Form 4
Jul 14, 2026GPCRCHIEF SCIENTIFIC OFFICERConversion of derivativeCode C · direct7,878—Form 4
Jul 14, 2026GPCRCHIEF SCIENTIFIC OFFICEROption exerciseCode M · direct23,634$8K@ $0.3400Form 4
Jun 25, 2026GPCRCHIEF SCIENTIFIC OFFICERConversion of derivativeCode C · direct7,878—Form 4
Jun 25, 2026GPCRCHIEF SCIENTIFIC OFFICEROption exerciseCode M · direct23,634$8K@ $0.3400Form 4
Mar 19, 2026GPCRCHIEF SCIENTIFIC OFFICERGrant or awardCode A · direct53,703—Form 4
Mar 19, 2026GPCRCHIEF SCIENTIFIC OFFICERGrant or awardCode A · direct43,368—Form 4
Mar 3, 2026GPCRCHIEF SCIENTIFIC OFFICERShares withheld for tax or exercise priceCode F · direct18,735$393K@ $20.99Form 4

How this page is built

Every row comes from a Form 4 filed with the SEC, which officers, directors and holders of more than 10% of a company’s stock must file within two business days of a trade. Transactions are grouped by the reporting owner’s name as filed (spacing, capitals and punctuation ignored); two different people filing under an identical name would appear together, and one person filing under two spellings appears on two pages.

Open-market totals count code P purchases and code S sales over the last 24 months. The same trade reported on more than one filing is counted once; when another owner (for example a fund and its general partner) reports the identical trade, they are listed beside it. Holdings are the shares owned after the latest purchase, sale, gift or tax-withholding line, shown separately for direct and indirect ownership; an indirect figure is one holding line, not a total across every trust or entity.

This page describes what was filed with the SEC; it is not investment advice or a recommendation to buy or sell any security.